Revilab ML-04
Longevity & Cellular HealthAlso known as: Revilab ML 04, ML-04
Bioregulators (Revilab Series)Research phase: Clinical use in Russia, no Western trialsRegulatory: Not FDA-approved. Available as bioregulator supplement in Russia and from international suppliers.
Mechanism
Revilab ML-04 is a multi-component capsule formulation targeting the cardiovascular system. It combines vascular, cardiac, and thymic bioregulatory peptides with cardiovascular-supportive nutrients.
Technical detail
Revilab ML-04 is a multi-component oral capsule containing bioregulatory peptides corresponding to Ventfort (vascular), Chelohart (cardiac), and Vladonix (thymic) cytomax sequences, combined with CoQ10, omega-3 fatty acids, and magnesium. It targets simultaneous endothelial function support, myocardial energetics optimization, and immune-mediated vascular protection.